Abbott Laboratories Inc. will be the only U.S. stent maker to co-offer advanced intravascular imaging and fractional flow reserve devices to help guide placement of its vascular stents, thanks to an expanded alliance with St. Jude Medical Inc. announced April 23.
Under the agreement, St. Jude’s interventional cardiology assessment tools – specifically intravascular optical coherence tomography (OCT) imaging and fractional flow reserve (FFR) – are added to an existing U.S. co-promotion...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?